Correction: Identification of novel COX-2 / CYP19A1 axis involved in the mesothelioma pathogenesis opens new therapeutic opportunities
J Exp Clin Cancer Res
.
2023 Jan 11;42(1):15.
doi: 10.1186/s13046-022-02539-3.
Authors
Barbara Nuvoli
1
,
Barbara Antoniani
2
,
Roberta Libener
3
,
Antonio Maconi
3
,
Andrea Sacconi
4
,
Mariantonia Carosi
2
,
Rossella Galati
5
Affiliations
1
Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
2
Anatomy Pathology Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
3
Department of Integrated Activities Research and Innovation, SS Antonio and Biagio General Hospital, Alessandria, Italy.
4
Clinical Trial Center, Biostatistics and Bioinformatics Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.
5
Preclinical Models and New Therapeutic Agents Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy. rossella.galati@ifo.gov.it.
PMID:
36627637
PMCID:
PMC9832804
DOI:
10.1186/s13046-022-02539-3
No abstract available
Publication types
Published Erratum